hepatitis C
Viral hepatitis
By understanding the various subtypes of hepatitis and the latest treatments available, pharmacists have a key role in educating, counselling and the ongoing management of patients with hepatitis. By Dr …
‘Impossible to predict’ how demand will unfold
Uncertainty thanks to the COVID-19 pandemic means Sigma won’t give full guidance as to earnings, but the wholesaler has achieved “outstanding” results, it says In a statement to the ASX …
Top 10 most common, most costly drugs
Drugs to treat Hepatitis C have cost the taxpayer more than $1 billion in 2018, and have topped the list of drugs ranked by cost to government in 2017-18 NPS …
Australia’s 10 most expensive drugs
Expensive medicines used to treat hepatitis C have cost the government more than any other drugs over the past year New figures based on PBS and RPBS scripts for the …
The week in review
For the most part, it’s been a positive week in Australian pharmacy The Pharmaceutical Society’s conference, PSA17, has seen a number of positive announcements made: Health Minister Greg Hunt declared …
PBS listing for first pan-genotypic antiviral hep C treatment
Hepatitis Australia has welcomed today’s announcement that a new hepatitis C drug will be listed on the PBS Epclusa, the first pan-genotypic antiviral, will be PBS listed from 1 August, …
Australia shines on viral hepatitis policy
We have one of the most comprehensive national hepatitis programs in the Asia-Pacific, survey finds The Asia Pacific Viral Hepatitis Policy Survey released this week has revealed how prepared different governments …
Hepatitis C eradication possible: expert
The new antivirals mean Australia is on track to eradicate hepatitis C, says one expert Associate Professor Simone Strasser, gastroenterologist at Royal Prince Alfred Hospital in Sydney, says the country …
PBS listing of hep C drugs leads to 10x uptake
More Australians were treated for hep C since DAAs were added to the PBS than in the past decade, according to new report Since direct-acting antiviral (DAA) hepatitis C treatments …
New once-daily Hep C treatment recommended for PBS
The first and only one-tablet, once-a-day treatment for all genotypes of chronic hepatitis C infection has been recommended for PBS listing Gilead Sciences Australia has announced that the TGA has …
Safety warning: DAAs linked to hepatitis B risk
The hep C medicines have been associated with reactivation of the hep B virus, which can lead to liver failure and even death A TGA review has found evidence of …
Research roundup
The latest in research news, as gathered by Debbie Rigby Pharmacokinetics and pharmacodynamics of sofosbuvir and ledipasvir for the treatment of hepatitis This article reviews the pharmacokinetic and pharmacodynamic properties …